Possible intranasal quetiapine misuse

American Journal of Health-System Pharmacy

Volumn 64, Issue 7, 2007, Pages 723-725

  Morin, Anna K ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Alcohols; Antipsychotic Agents; Benztropine; Bipolar Disorder; Cocaine; Diphenhydramine; Drug Abuse; Drug administration routes; Ethyl; Haloperidol; Lorazepam; Quetiapine; Trazodone

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; BENZATROPINE; COCAINE; DIPHENHYDRAMINE; HALOPERIDOL; LORAZEPAM; QUETIAPINE; TRAZODONE;

ADULT; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; CASE REPORT; CLINICAL FEATURE; COCAINE DEPENDENCE; COMORBIDITY; DRUG MISUSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HOSPITALIZATION; HUMAN; MULTIPLE DRUG ABUSE; PERSONALITY DISORDER; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SYMPTOM; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 34047122032     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060226     Document Type: Article

References (16)

1. Seroquel (quetiapine fumarate) prescribing information. Wilmington, DE: AstraZeneca Pharmaceuticals; 2005 Jun.
2. Factor SA. Pharmacology of atypical antipsychotics. Clin Nephrol. 2002; 25:153-7.
3. Kapur S, Zipursky R, Jones C et al. A positron emission tomography study of quetiapine in schizophrenia. Arch Gen Psychiatry. 2000; 57:553-9.
4. Tauscher J, Hussain T, Agid O et al. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry. 2004; 161:1620-5.
5. Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353:1209-23.
6. Daly PA, Krieger ER, Dulloo AG et al. Ephedrine, caffeine, and aspirin: safety and efficacy for treatment of human obesity. Int J Obes Relat Metab Disord. 1993; 17(suppl 1):S73-8.
7. Pierre JM, Shnayder I, Wirshing DA et al. Intranasal quetiapine abuse. Am J Psychiatry. 2004; 161:1781. Letter.
8. Hussain MZ, Waheed W, Hussain S. Intravenous quetiapine abuse. Am J Psychiatry. 2005; 162:1755-6.
9. Adityanjee, Schulz C. Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry. 2002; 63(suppl 13):32-8.
10. Sattar SP, Bhatia SC, Petty F. Potential benefits of quetiapine in the treatment of substance dependence disorders. Rev Psychiatry Neurosci. 2004; 29:452-7.
11. Weisnam RL. Quetiapine in the successful treatment of schizophrenia with comorbid alcohol and drug dependence: a case report. Int J Psychiatry Med. 2003; 33:85-9.
12. Monnelly EP, Ciraulo DA, Knapp C et al. Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol. 2004; 24:532-5.
13. Pinkofsky HB, Hahn AM, Campbell FA et al. Reduction of opioid-withdrawal symptoms with quetiapine. J Clin Psychiatry. 2005; 66:1285-8.
14. Brown ES, Nejtek VA, Perantie DC et al. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002; 4:406-11.
15. Cohrs S, Rodenbeck A, Guan Z et al. Sleep promoting properties of quetiapine in healthy subjects. Psychopharmacology. 2004; 174:421-9.
16. Arango C, Bobes J. Managing acute exacerbations of schizophrenia: focus on quetiapine. Curr Med Res Opin. 2004; 20:619-26.